Stock listing

OTC:AURX Nuo Therapeutics Inc Stock

Follow Nuo Therapeutics Inc into a list and get an email when it puts out news.

Share price · OTC:AURX

$0.914 USD -0.177 (-16.2%)

Close on Nov 20, 2026

Past year -60.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.914 – $1.050 USDNov 20, 2026
Volume
11,100 sharesNov 20, 2026
Market cap
$44.38M USDAt the close on Nov 20, 2026 · price × 48.59M shares outstanding
52-week range
$0.770 – $2.290 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$6,872 USDMedian day 1,200 shares · 12 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Nuo Therapeutics Inc logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:AURX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.914-0.177-16.2%$1.050$1.050$0.91411,100
$1.090+0.020+1.9%$1.090$1.090$1.090300
$1.0700.0000.0%$1.090$1.090$1.070702
$1.070-0.188-14.9%$1.200$1.200$1.0701,500
$1.258-0.012-1.0%$1.250$1.258$1.250200
$1.2700.0000.0%$1.270$1.270$1.2701,000
$1.270-0.030-2.3%$1.280$1.280$1.2706,161
$1.3000.0000.0%$1.300$1.300$1.29025,206
$1.3000.0000.0%$1.300$1.300$1.300100
$1.300+0.050+4.0%$1.250$1.300$1.25010,000
$1.250-0.010-0.8%$1.260$1.260$1.2501,652
$1.260-0.040-3.1%$1.280$1.300$1.25069,836
$1.3000.0000.0%$1.300$1.300$1.3000
$1.300-0.010-0.8%$1.300$1.300$1.26027,700
$1.310+0.010+0.8%$1.310$1.310$1.310357
$1.3000.0000.0%$1.303$1.303$1.300276
$1.3000.0000.0%$1.300$1.300$1.3000
$1.3000.0000.0%$1.300$1.300$1.3006,501
$1.3000.0000.0%$1.300$1.300$1.3000
$1.3000.0000.0%$1.300$1.300$1.3003,749
$1.300+0.050+4.0%$1.300$1.300$1.300244
$1.2500.0000.0%$1.250$1.250$1.2500
$1.2500.0000.0%$1.250$1.250$1.2500
$1.2500.0000.0%$1.250$1.250$1.2500
$1.2500.0000.0%$1.250$1.250$1.250200
$1.250-0.070-5.3%$1.304$1.304$1.250841
$1.320+0.070+5.6%$1.320$1.320$1.320800
$1.250-0.033-2.6%$1.265$1.265$1.25010,007
$1.2830.0000.0%$1.283$1.283$1.2830
$1.283-0.017-1.3%$1.250$1.283$1.2504,200
$1.3000.0000.0%$1.300$1.300$1.3000
$1.3000.0000.0%$1.300$1.300$1.3000
$1.300+0.060+4.8%$1.250$1.300$1.2502,100
$1.240-0.020-1.6%$1.270$1.270$1.2004,037
$1.2600.0000.0%$1.260$1.260$1.2605,000
$1.260+0.010+0.8%$1.260$1.260$1.2602,194
$1.2500.0000.0%$1.250$1.250$1.2500
$1.2500.0000.0%$1.281$1.281$1.250600
$1.250+0.020+1.6%$1.250$1.250$1.2507,600
$1.230+0.040+3.4%$1.210$1.240$1.21011,535
$1.190-0.020-1.7%$1.190$1.190$1.190100
$1.210+0.100+9.0%$1.210$1.210$1.210500
$1.110-0.100-8.3%$1.178$1.210$1.1101,672
$1.210+0.070+6.1%$1.185$1.210$1.18516,721
$1.1400.0000.0%$1.140$1.140$1.1400
$1.140+0.040+3.6%$1.100$1.140$1.1006,043
$1.100+0.030+2.8%$1.132$1.132$1.08010,222
$1.070+0.023+2.2%$1.070$1.110$1.05517,600
$1.047-0.003-0.3%$1.047$1.050$1.0477,000
$1.050-0.020-1.9%$1.050$1.050$1.05010,000
$1.070+0.040+3.9%$1.040$1.070$1.04014,272
$1.030+0.030+3.0%$1.020$1.030$1.0201,200
$1.0000.0000.0%$1.000$1.000$1.0000
Ticker
OTC:AURX
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
OTC
Currency
USD

What changed lately

Latest news

All Nuo Therapeutics Inc news

Nuo Therapeutics Inc on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
1 in the last 12 months · 1 in all · newest Nov 16, 2026 · oldest 2026

Valuation

EV/sales 7.3× against a median of 2.6×: 7th lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$44.30M USD
P/E
Loss
EV/sales
7.3×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
64.6%
Operating margin
−26.0%
Net margin
−31.5%
Debt to equity
Negative equity
Beta vs S&P 500
0.73

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Nuo Therapeutics Inc · OTC:AURXUS$44.38MUS$44.30Mn/a7.3×n/an/a−31.5%n/a0.73
Medimaging Integrated Solution Inc. · TWSE:6796US$48.04MUS$43.05M111×2.1×28.6×1.9×2.1%0.5×n/a
Conexeu Sciences Inc. · NASDAQ:CNXUUS$47.79MUS$45.82Mn/an/an/a8.2×n/a0.0×2.08
Microbot Medical Inc. · NASDAQ:MBOTUS$45.67M−US$16.16Mn/a−38.6×n/a0.7×n/a0.0×1.82
RenovoRx, Inc. · NASDAQ:RNXTUS$45.45MUS$35.27Mn/a12.7×n/a4.9×−469.0%0.0×1.71
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. · BIST:ONCSMUS$45.28MUS$45.31M31.7×2.9×7.5×4.5×9.0%0.1×n/a
Somnomed Limited · ASX:SOMUS$45.09MUS$37.33Mn/a0.5×8.7×1.4×−2.3%0.1×n/a
Bactiguard Holding AB · OMXSTO:BACTI_BUS$45.09MUS$54.74M76.6×2.6×12.5×1.5×2.8%0.5×n/a
Ortoma AB Class B · OMXSTO:ORT_BUS$44.22MUS$38.08Mn/a11.7×n/a2.6×−197.7%0.0×n/a
BrainCool AB · OMXSTO:BRAINUS$43.26MUS$39.04Mn/a9.8×n/a2.8×−84.7%0.0×n/a
Corentec Co., Ltd. · KRX:104540US$42.84MUS$24.22M8.5×0.3×2.3×0.7×6.4%0.0×n/a
Median of the othersUS$45.19MUS$38.56M54.1×2.6×8.7×2.2×−0.1%0.0×1.82

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
3.00 USD · Analysts' mean
EPS, year to Dec 2026
-0.040 · 1 analyst

Events

QuarterResultsShare move
Q2 2026Sep 2, 2026−2.6%
Q1 2026May 15, 20260.0%
Q4 2025Mar 30, 2026 · After close+0.7%
Q3 2025Dec 3, 20250.0%
Q1 2025May 13, 2025 · After close0.0%
Q3 2024Nov 18, 2024 · After close+5.6%
Q2 2024Aug 12, 2024 · Before open+81.2%
Q1 2024May 15, 2024 · After close0.0%
Q4 2023Feb 5, 2024 · Before open−3.2%
Q3 2023Nov 20, 2023 · After close−6.5%
All 12 quarters
QuarterResultsShare move
Q2 2023Aug 14, 2023 · After close0.0%
Q1 2023May 15, 2023 · After close0.0%

Open Events

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
Revenue3.31M1.37M608.5K112.3K00146.2K1.37M721.0K11.5M
Cost of revenue1.10M302.8K126.1K19.2K00114.6K163.0K1.09M7.97M
Gross profit2.22M1.06M482.4K93.0K0031.6K1.21M-370.0K3.54M
Research and development00181.2K576.2K1.33M2.55M
Selling, general and administrative4.73M3.52M3.65M3.41M90.7K
Operating income-2.52M-2.46M-3.17M-3.32M-90.7K-378.1K-969.2K-1.50M-15.5M-41.3M
Depreciation and amortization85.5K23.0K15.3K6.83K0089.9K102.2K1.11M741.0K
EBITDA-2.43M-2.43M-3.15M-3.31M-90.7K-378.1K-879.3K-1.40M-14.4M-40.6M
Interest expense048.4K221.5K38.9K10.8K
Income before tax-2.51M-2.32M-3.17M-3.17M-90.7K-90.9K-1.19M-1.54M-15.0M-52.9M
Income tax0000000-89.0K
Net income-2.51M-2.32M-3.17M-3.17M-90.7K-90.9K-1.19M-1.54M-15.0M-52.8M
Earnings per share, basic-0.05-0.05-0.08-0.08-0.030.30-0.05-0.07-1.02-0.42
Earnings per share, diluted-0.030.27-0.05-0.07-1.02-0.42

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
Cash and equivalents548.9K283.7K928.7K2.05M1.41M161.4K20.3K636.9K693.5K922.3K
Receivables561.7K248.2K250.7K92.3K0
Inventory213.8K150.4K209.6K240.0K025.3K35.6K254.4K
Current assets1.38M841.5K1.56M2.63M1.47M161.4K276.5K866.7K1.19M3.05M
Property, plant and equipment366.3K177.0K45.1K53.2K000105.5K223.6K1.12M
Goodwill00
Total assets1.85M1.19M1.88M3.05M1.47M161.4K276.5K975.5K1.42M7.07M
Accounts payable436.1K219.2K394.5K397.7K526.6K518.4K538.7K437.3K380.3K1.07M
Current liabilities1.31M578.5K674.5K600.4K673.1K665.0K1.49M1.06M936.8K42.2M
Total debt00
Total liabilities2.80M675.8K838.7K856.0K673.1K665.0K1.49M1.06M941.2K43.1M
Shareholders' equity-956.6K513.7K1.04M2.19M792.8K-503.5K-1.21M-82.0K482.9K-36.6M
Shares outstanding48.2M46.8M44.2M41.8M37.1M30.3M23.7M23.7M22.7M125.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
Cash from operations-865.0K-2.23M-3.17M-3.71M-120.0K-53.8K-921.7K-874.4K-4.90M-14.4M
Capital spending-274.8K-155.0K-7.24K-60.0K000-698.2K
Free cash flow-1.14M-2.39M-3.18M-3.77M-120.0K-53.8K-921.7K-15.1M
Cash from investing-274.8K-155.0K-7.24K-60.0K0002.00K1.91K-629.4K
Cash from financing1.40M1.74M2.00M4.46M1.37M195.0K305.0K815.8K2.92M0
Share buybacks-471
Change in cash265.2K-645.0K-1.18M691.6K1.25M141.2K-616.7K-56.6K-1.98M-15.0M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 17, 2026ResultsSEC
10-Q · Quarterly reportNov 13, 2026Quarterly reportSEC
4 · Change in ownershipOct 6, 2026Insider tradeSEC
8-K · Current reportOct 6, 2026Material contractSEC
4/A · Change in ownership, amendedAug 31, 2026Insider tradeSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
8-K · Current reportAug 17, 2026ResultsSEC
10-Q · Quarterly reportAug 14, 2026Quarterly reportSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 3, 2026Big-stake noticeSEC
4 · Change in ownershipJun 2, 2026Insider tradeSEC
4/A · Change in ownership, amendedJun 2, 2026Insider tradeSEC
8-K · Current reportJun 2, 2026Material contractSEC
8-K · Current reportMay 14, 2026ResultsSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
10-K · Annual reportMar 30, 2026Annual reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2026Big-stake noticeSEC
4 · Change in ownershipJan 26, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 26, 2026Big-stake noticeSEC
8-K · Current reportJan 26, 2026Material contractSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
8-K · Current reportDec 17, 2025Meeting outcomeSEC
4/A · Change in ownership, amendedDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
10-Q · Quarterly reportOct 30, 2025Quarterly reportSEC
DEFA14A · Additional proxy materialOct 30, 2025Meeting noticeSEC
DEF 14A · Proxy statementOct 30, 2025Meeting noticeSEC
8-K · Current reportOct 10, 2025Management or board changeSEC
DAug 4, 2025Other filingsSEC
4/A · Change in ownership, amendedAug 4, 2025Insider tradeSEC
4 · Change in ownershipAug 4, 2025Insider tradeSEC
4 · Change in ownershipAug 4, 2025Insider tradeSEC
4 · Change in ownershipAug 4, 2025Insider tradeSEC
4 · Change in ownershipAug 4, 2025Insider tradeSEC
4 · Change in ownershipAug 1, 2025Insider tradeSEC
4 · Change in ownershipAug 1, 2025Insider tradeSEC
10-Q · Quarterly reportJul 31, 2025Quarterly reportSEC
8-K · Current reportMay 15, 2025Material contractSEC
EFFECT · Notice that a registration is effectiveMay 13, 2025Other filingsSEC
S-3/A · Registration statement, amendedMay 8, 2025Offer documentSEC
CORRESP · Letter to the SECMay 8, 2025Other filingsSEC
UPLOAD · Letter from the SECMay 6, 2025Other filingsSEC
S-3 · Registration statementMay 1, 2025Offer documentSEC
10-Q · Quarterly reportApr 30, 2025Quarterly reportSEC
S-8 · Registration statement for employee plansApr 10, 2025Offer documentSEC
10-K · Annual reportApr 1, 2025Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2025Explanation requestSEC
4 · Change in ownershipNov 19, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedOct 22, 2024Big-stake noticeSEC
DSep 20, 2024Other filingsSEC
4 · Change in ownershipSep 19, 2024Insider tradeSEC
8-K · Current reportSep 19, 2024Material contractSEC
10-Q · Quarterly reportAug 12, 2024Quarterly reportSEC
4 · Change in ownershipJul 22, 2024Insider tradeSEC
4 · Change in ownershipJul 22, 2024Insider tradeSEC
4 · Change in ownershipJul 22, 2024Insider tradeSEC
8-K · Current reportJun 27, 2024Current reportSEC
8-K · Current reportJun 11, 2024Current reportSEC
DMay 22, 2024Other filingsSEC
4 · Change in ownershipMay 21, 2024Insider tradeSEC
4 · Change in ownershipMay 21, 2024Insider tradeSEC
4 · Change in ownershipMay 21, 2024Insider tradeSEC
8-K · Current reportMay 21, 2024Material contractSEC
10-Q · Quarterly reportMay 15, 2024Quarterly reportSEC
10-K · Annual reportApr 19, 2024Annual reportSEC
8-K · Current reportApr 16, 2024Current reportSEC
NT 10-K · Late filing noticeApr 1, 2024Explanation requestSEC
SC 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 12, 2024Big-stake noticeSEC
DDec 22, 2023Other filingsSEC
SC 13D/A · Big-stake notice, amendedDec 20, 2023Big-stake noticeSEC
4 · Change in ownershipDec 20, 2023Insider tradeSEC
4 · Change in ownershipDec 20, 2023Insider tradeSEC
4 · Change in ownershipDec 20, 2023Insider tradeSEC
8-K · Current reportDec 20, 2023Material contractSEC
10-Q · Quarterly reportNov 20, 2023Quarterly reportSEC
NT 10-Q · Late filing noticeNov 15, 2023Explanation requestSEC
10-Q · Quarterly reportAug 14, 2023Quarterly reportSEC
DAug 8, 2023Other filingsSEC
4 · Change in ownershipAug 4, 2023Insider tradeSEC
4 · Change in ownershipAug 3, 2023Insider tradeSEC
4 · Change in ownershipAug 3, 2023Insider tradeSEC
8-K · Current reportAug 3, 2023Material contractSEC
10-Q · Quarterly reportMay 15, 2023Quarterly reportSEC
10-K/A · Annual report, amendedApr 17, 2023Annual reportSEC
10-K · Annual reportApr 14, 2023Annual reportSEC
NT 10-K · Late filing noticeMar 31, 2023Explanation requestSEC
8-K · Current reportDec 5, 2022Meeting outcomeSEC
4 · Change in ownershipNov 14, 2022Insider tradeSEC
10-Q · Quarterly reportNov 4, 2022Quarterly reportSEC
10-Q · Quarterly reportNov 4, 2022Quarterly reportSEC
DEFA14A · Additional proxy materialOct 20, 2022Meeting noticeSEC
DEF 14A · Proxy statementOct 20, 2022Meeting noticeSEC
3/A · Initial statement of ownership, amendedOct 18, 2022Insider tradeSEC
8-K · Current reportSep 30, 2022Current reportSEC
8-K · Current reportAug 30, 2022Material contractSEC
10-Q/A · Quarterly report, amendedAug 10, 2022Quarterly reportSEC
10-Q · Quarterly reportAug 8, 2022Quarterly reportSEC
SC 13D/A · Big-stake notice, amendedJul 5, 2022Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedJul 5, 2022Big-stake noticeSEC
SC 13D · Big-stake noticeJul 5, 2022Big-stake noticeSEC
8-K · Current reportJun 28, 2022Current reportSEC
4 · Change in ownershipJun 15, 2022Insider tradeSEC
DMay 19, 2022Other filingsSEC
10-Q · Quarterly reportMay 16, 2022Quarterly reportSEC
DMay 6, 2022Other filingsSEC
4 · Change in ownershipMay 2, 2022Insider tradeSEC
4 · Change in ownershipMay 2, 2022Insider tradeSEC
4 · Change in ownershipMay 2, 2022Insider tradeSEC
4 · Change in ownershipMay 2, 2022Insider tradeSEC
8-K · Current reportMay 2, 2022Material contractSEC
DEF 14CApr 27, 2022Meeting noticeSEC
3 · Initial statement of ownershipApr 26, 2022Insider tradeSEC
4 · Change in ownershipApr 26, 2022Insider tradeSEC
4 · Change in ownershipApr 26, 2022Insider tradeSEC
4 · Change in ownershipApr 26, 2022Insider tradeSEC
4 · Change in ownershipApr 26, 2022Insider tradeSEC
4 · Change in ownershipApr 26, 2022Insider tradeSEC
5 · Annual statement of ownershipApr 26, 2022Insider tradeSEC
5 · Annual statement of ownershipApr 26, 2022Insider tradeSEC
5 · Annual statement of ownershipApr 26, 2022Insider tradeSEC
5 · Annual statement of ownershipApr 26, 2022Insider tradeSEC
5 · Annual statement of ownershipApr 26, 2022Insider tradeSEC
5 · Annual statement of ownershipApr 26, 2022Insider tradeSEC
5 · Annual statement of ownershipApr 26, 2022Insider tradeSEC
5 · Annual statement of ownershipApr 26, 2022Insider tradeSEC
5 · Annual statement of ownershipApr 26, 2022Insider tradeSEC
10-K · Annual reportApr 15, 2022Annual reportSEC
NT 10-K · Late filing noticeMar 31, 2022Explanation requestSEC
SC TO-T/AMar 21, 2022Acquisition or disposalSEC
SC 14D9Feb 4, 2022Acquisition or disposalSEC
SC TO-TJan 21, 2022Acquisition or disposalSEC
8-K · Current reportJan 4, 2022Material contractSEC
8-K · Current reportApr 21, 2021Current reportSEC
SC 13G · Big-stake noticeOct 9, 2020Big-stake noticeSEC
8-K · Current reportOct 6, 2020Material contractSEC
8-K · Current reportApr 13, 2020Current reportSEC
8-K · Current reportMar 30, 2020Current reportSEC
10-Q · Quarterly reportJan 31, 2020Quarterly reportSEC
8-K · Current reportDec 12, 2019Material contractSEC
8-K · Current reportNov 20, 2019Material contractSEC
NT 10-Q · Late filing noticeNov 13, 2019Explanation requestSEC
10-Q · Quarterly reportAug 19, 2019Quarterly reportSEC
NT 10-Q · Late filing noticeAug 14, 2019Explanation requestSEC
8-K · Current reportAug 9, 2019Material contractSEC
8-K · Current reportJun 13, 2019Material contractSEC
10-Q · Quarterly reportMay 20, 2019Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2019Explanation requestSEC
8-K · Current reportMay 7, 2019Material contractSEC
PRE 14A · Preliminary proxy statementApr 17, 2019Meeting noticeSEC
10-K · Annual reportApr 16, 2019Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2019Explanation requestSEC
8-K · Current reportMar 22, 2019Material contractSEC
8-K · Current reportJan 15, 2019Current reportSEC
8-K · Current reportJan 3, 2019Management or board changeSEC
4 · Change in ownershipJan 3, 2019Insider tradeSEC
4 · Change in ownershipJan 3, 2019Insider tradeSEC
4 · Change in ownershipJan 3, 2019Insider tradeSEC
4 · Change in ownershipJan 3, 2019Insider tradeSEC
4 · Change in ownershipJan 3, 2019Insider tradeSEC
4 · Change in ownershipJan 3, 2019Insider tradeSEC
10-Q · Quarterly reportNov 16, 2018Quarterly reportSEC
NT 10-Q · Late filing noticeNov 14, 2018Explanation requestSEC
8-K · Current reportOct 26, 2018Material contractSEC
8-K · Current reportOct 2, 2018Material contractSEC
8-K · Current reportSep 21, 2018Material contractSEC
8-K · Current reportSep 5, 2018Meeting outcomeSEC
DEF 14A · Proxy statementAug 28, 2018Meeting noticeSEC
PRE 14A · Preliminary proxy statementAug 15, 2018Meeting noticeSEC
10-Q · Quarterly reportAug 13, 2018Quarterly reportSEC
4 · Change in ownershipAug 13, 2018Insider tradeSEC
4 · Change in ownershipAug 13, 2018Insider tradeSEC
4 · Change in ownershipAug 13, 2018Insider tradeSEC
4 · Change in ownershipAug 13, 2018Insider tradeSEC
4 · Change in ownershipAug 13, 2018Insider tradeSEC
4 · Change in ownershipAug 13, 2018Insider tradeSEC
8-K · Current reportAug 10, 2018Management or board changeSEC
8-K · Current reportJun 28, 2018Management or board changeSEC
DJun 12, 2018Other filingsSEC
8-K · Current reportMay 30, 2018Material contractSEC
10-Q · Quarterly reportMay 14, 2018Quarterly reportSEC
10-K · Annual reportApr 16, 2018Annual reportSEC
8-K · Current reportApr 4, 2018Current reportSEC
NT 10-K · Late filing noticeApr 2, 2018Explanation requestSEC
8-K · Current reportJan 19, 2018Management or board changeSEC
PRE 14A · Preliminary proxy statementDec 13, 2017Meeting noticeSEC
10-Q · Quarterly reportNov 13, 2017Quarterly reportSEC
8-K · Current reportSep 28, 2017Current reportSEC
SC 13D/A · Big-stake notice, amendedSep 21, 2017Big-stake noticeSEC
4 · Change in ownershipSep 21, 2017Insider tradeSEC
8-K · Current reportSep 14, 2017FinancingSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Nuo Therapeutics Inc’s releases · as of Nov 12, 2026

Common shares
48,585,593
Fully diluted
48,585,593

Fully diluted

LineSharesAs of
Common shares48,585,593Nov 12, 2026

Share count over time

CountShares
Nov 12, 202648,585,593
Sep 30, 202648,573,894

Open Cap table

Shareholders

HolderSharesOf the companyValueAs of
Ancora Advisors LLC4,700<0.01%US$5,875Sep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Steven Shallcross
Other companies: Theriva Biologics, Inc. (Chief Executive Officer, Chief Financial Officer, Director · Since at least Jun 1, 2015); Twin Vee PowerCats Co. (Director · Jul 20, 2021 – Jul 23, 2021 · Past); Vanda Pharmaceuticals Inc. (Sr. VP, CFO, Treasurer · Apr 12, 2006 – Jan 4, 2008 · Past)
Chief Financial Officer · Mar 30, 2013 – Aug 26, 2014 · Past
Edward L Field
Other companies: BioRestorative Therapies, Inc. (President brtxDISC Division · Feb 9, 2015 – Jul 12, 2017 · Past)
CHIEF OPERATING OFFICER · Feb 8, 2012 – Apr 8, 2014 · Past
Lawrence Atinsky
Other companies: Deerfield Healthcare Technology Acquisitions Corp (Director · Jul 16, 2020 – Jul 16, 2020 · Past)
Director · May 5, 2016 – Dec 31, 2018 · Past
Carelyn P FyllingVP of Professional Sevices · Jan 12, 2006 – Sep 17, 2009 · Past
C Eric WinzerDirector · Since at least May 5, 2016
David Emerson JordenCEO/CFO, Director · Since at least Aug 9, 2018
Martin P RosendaleChief Executive Officer, Director · Mar 14, 2008 – Aug 20, 2014 · Past
Paul MintzDirector · Since at least Mar 4, 2022
Peter ClausenCSO/COO · Since at least Jul 31, 2025
Scott M PittmanDirector · Since at least May 5, 2016
All 11 people
PersonSeat
Stephen KeithDirector · Jan 28, 2014 – Jan 2, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about Nuo Therapeutics Inc.